Clinical trials
Bleeding clinical trials
Below are recruiting bleeding clinical trials, each written for real people, not researchers. We’re tracking 270 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06848400Recruiting
Capsule endoscopy for stomach screening at home
This trial tests if a capsule-sized camera can be used at home to check for stomach problems. It's for healthy people or those with stomach symptoms like pain, nausea, or bleeding.
Guangzhou, GuangdongAges 18 years+ - NCT06868823Recruiting
Blood thinners during lung transplant bypass
This study compares two different blood thinners (UFH and LMWH) used during heart-lung bypass (ECMO) for double lung transplant patients. The goal is to see which one works better and is safer.
Prague, Czech RepublicAges 18 years+ - NCT06878066RecruitingPhase 3
Clot-busting treatment after stroke while on Factor Xa inhibitor
This trial tests a clot-busting drug (thrombolysis) for people who had a stroke while on a Factor Xa inhibitor blood thinner. It aims to see if the drug can still safely break up the clot and reduce disability.
Bærum, GjettumAges 18 years+ - NCT06882564RecruitingPhase 3
Resveratrol mouthwash for bad breath study
This trial tests whether a special mouthwash with resveratrol (a natural plant compound) can help reduce bad breath caused by gum-related bacteria. It might be a good option if you have bad breath from gingivitis (mild gum inflammation) and are a non-smoking dental student.
Baghdad, Bab Al-MoadhamAges 20–24 - NCT06890312Recruiting
Timing of blood thinner during heart catheterization
This study looks at the best time to give a standard blood thinner (heparin) during a heart procedure called angioplasty, which opens blocked heart arteries through a wrist artery. It may help reduce bleeding or clotting risks.
Strasbourg, Bas-RhinAges 18 years+ - NCT06947044Recruiting
Blood markers for bleeding in leukemia patients
This study looks at markers in the blood to understand why low red blood cell counts (anemia) can cause bleeding problems in people with certain leukemias. It may help find better ways to treat or prevent bleeding during early chemotherapy.
Hamilton, OntarioAges 18 years+ - NCT06953076Recruiting
Ultrasound changes in fibroids during Relugolix treatment
This study tests whether an ultrasound can show how fibroids (benign uterine growths) change during treatment with a medication called Relugolix (combined with estrogen and progestin). It's for women who have heavy bleeding and want to know if the medication can shrink their fibroids.
RomaAges 18 years+ - NCT06957366Recruiting
Managing Blood Thinners Before High-Risk Surgery
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
Hartford, ConnecticutAges 18 years+ - NCT06961175Recruiting
Platelet function study in heart surgery
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
SalamancaAges 18 years+ - NCT06969326RecruitingPhase 3
Estrogen cream after hysterectomy for transgender men
This study tests whether using a topical estrogen cream after hysterectomy surgery can help transgender men have a better recovery. Participants will be randomly assigned to use the cream or not, and researchers will follow up by text message.
Providence, Rhode IslandAges 18 years+ - NCT07025954Recruiting
Delivery at 36 vs. 37 weeks for placenta previa with accreta
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
Guangzhou, GuangdongAges 18–45 - NCT07039149Recruiting
Dual antiplatelet therapy for acute coronary syndrome
This trial tests giving two blood-thinning medicines early to people who have had a heart attack or unstable chest pain. Researchers want to see if this approach reduces future heart problems.
AmmanAges 18 years+ - NCT07052799RecruitingPhase 3
Should you pause aspirin before a colonoscopy?
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Hong KongAges 18 years+ - NCT07072364Recruiting
Videos to help decide on fibroid treatment
This study tests if watching short videos helps people with uterine fibroids make better treatment decisions with their doctor. You are eligible if you have fibroids and are scheduled to discuss options at a Penn Medicine clinic.
Philadelphia, PennsylvaniaAges 18–55 - NCT07083635RecruitingPhase 2
Hormonal patch for irregular bleeding with contraceptive implant
This trial tests a skin patch containing two hormones (estrogen and progestin) to see if it can stop irregular bleeding in women who have a contraceptive implant. If you're having unpredictable or prolonged bleeding with your implant, this treatment may help regulate your periods.
Pathum Wan, BangkokAges 18 years+ - NCT07084714Recruiting
Can moderate exercise help with period symptoms?
This trial tests whether moderate aerobic exercise can help manage menstrual cycle symptoms in people who are not very active. You would exercise for a few weeks while tracking your symptoms to see if exercise makes a difference.
Colorado Springs, ColoradoAges 18–40 - NCT07089030Recruiting
Capsule endoscopy for unexplained anemia on blood thinners
This study uses a capsule endoscopy (a pill-sized camera you swallow) to look for hidden sources of bleeding in the small intestine of people who have iron deficiency anemia and take blood thinners. Finding the cause may help manage your anemia and avoid unnecessary repeat tests.
Trois-Rivières, QuebecAges 18–90 - NCT07157423RecruitingPhase 4
A study of a medicine for heavy bleeding after childbirth in India
This study tests a medicine called eptacog alfa to see if it is safe for women in India who have severe bleeding after giving birth. It is for women who did not get better with standard treatments to help the uterus contract.
Belagavi, KarnatakaAges 18 years+ - NCT07183501Recruiting
Fixing C-section scar defect with two scopes
This trial tests a surgery using two tools (a scope for the uterus and a small belly camera) to repair a defect from a past C-section that causes spotting after periods. It may help women with this symptom.
Asyut, Asyut GovernorateAges 20–45 - NCT07183605Recruiting
How different ways of drawing blood from a central line compare for heparin activity
This trial checks whether blood samples taken from a central line using either a syringe flush or a vacuum tube give the same heparin activity results as blood from a vein in the arm. It is designed for patients in the ICU who are on a steady heparin drip.
OrléansAges 18 years+ - NCT07205523Recruiting
High-altitude blood study for stem cell transplant patients
This study observes how blood and stem cell transplants work for patients with blood diseases at high altitude. It aims to learn more to help future patients.
Xining, QinghaiAges Any age - NCT07230847Recruiting
Healing of drug-coated vs. standard stents in high-bleeding-risk patients
This trial compares two types of stents (a drug-coated stent and a standard drug-eluting stent) in people with acute coronary syndrome who also have a high risk of bleeding. It uses a special camera to look at how the artery heals one month after the stent is placed.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05022459Recruiting
Prevent bleeding in kids with Hemophilia A who play sports
This study compares two ways to prevent bleeding in people with Hemophilia A while they play sports. It looks at whether factor VIII or emicizumab prophylaxis helps reduce bleeding during higher-risk sports activities.
Little Rock, ArkansasAges 6–19 - NCT07253389Recruiting
Comparing two TIPS techniques to prevent variceal rebleeding in cirrhosis
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
Xi'an, ShaanxiAges 18–75
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bleeding?
- Yes. Clin2 currently lists 270 recruiting bleeding studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bleeding trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bleeding trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.